Pediatrix Medical Group, Inc. $MD Shares Sold by Rhumbline Advisers

Rhumbline Advisers reduced its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 3.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 216,946 shares of the company’s stock after selling 7,755 shares during the period. Rhumbline Advisers owned 0.25% of Pediatrix Medical Group worth $3,144,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of MD. BNP Paribas Financial Markets raised its position in shares of Pediatrix Medical Group by 87.8% during the 4th quarter. BNP Paribas Financial Markets now owns 34,776 shares of the company’s stock worth $456,000 after purchasing an additional 16,256 shares during the last quarter. Deutsche Bank AG raised its holdings in Pediatrix Medical Group by 53.1% in the 4th quarter. Deutsche Bank AG now owns 74,023 shares of the company’s stock valued at $971,000 after acquiring an additional 25,663 shares during the last quarter. Gotham Asset Management LLC raised its holdings in Pediatrix Medical Group by 38.0% in the 4th quarter. Gotham Asset Management LLC now owns 54,642 shares of the company’s stock valued at $717,000 after acquiring an additional 15,044 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Pediatrix Medical Group by 6.1% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 49,002 shares of the company’s stock valued at $643,000 after acquiring an additional 2,801 shares during the last quarter. Finally, Nuveen Asset Management LLC raised its holdings in Pediatrix Medical Group by 110.8% in the 4th quarter. Nuveen Asset Management LLC now owns 485,587 shares of the company’s stock valued at $6,371,000 after acquiring an additional 255,273 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have weighed in on MD. UBS Group boosted their price target on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a “neutral” rating in a report on Thursday, August 14th. Leerink Partners boosted their price target on Pediatrix Medical Group from $14.50 to $17.00 and gave the company a “market perform” rating in a report on Friday, September 5th. Wall Street Zen downgraded Pediatrix Medical Group from a “strong-buy” rating to a “buy” rating in a report on Saturday. Finally, Zacks Research upgraded Pediatrix Medical Group to a “strong-buy” rating in a report on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $16.79.

Pediatrix Medical Group Stock Down 0.5%

Shares of NYSE MD opened at $16.56 on Tuesday. Pediatrix Medical Group, Inc. has a 12-month low of $10.39 and a 12-month high of $17.67. The company has a market cap of $1.44 billion, a P/E ratio of 12.83 and a beta of 1.29. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. The stock has a fifty day moving average price of $14.81 and a 200 day moving average price of $14.18.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The firm had revenue of $468.84 million during the quarter, compared to the consensus estimate of $464.37 million. During the same period in the prior year, the firm earned $0.34 EPS. The firm’s quarterly revenue was down 7.1% compared to the same quarter last year. Research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.